Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06887933 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Trial to Evaluate the Safety of Niraparib Tablets in Adult Female Participants With Advanced or Relapsed Epithelial Ovarian Cancer

StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 21, 2025 (before its estimated March 20, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
GlaxoSmithKline
246 trials monitored
See 20 trials at risk
Ovarian Cancer
1,336 trials monitored
See 90 trials at risk
The goal of this clinical trial is to learn about the safety profile of niraparib in adult female participants for the treatment of advanced or relapsed epithelial ovarian cancer.
Trial Details
NCT Number NCT06887933
Lead Sponsor GlaxoSmithKline
Conditions
(from sponsor)		 Ovarian Neoplasms
Related terms Ovarian Neoplasms
Enrollment 67 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov